New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2013
11:22 EDTIDXXIDEXX says FTC grants final approval of consent agreement
IDEXX Laboratories announced that the Commissioners of the U.S. Federal Trade Commission have granted final approval of the consent agreement previously reached between the company and the staff of the FTC Bureau of Competition. The Commission had preliminarily approved the consent agreement in December 2012 and placed the agreement and a proposed draft complaint on public record for comment.The company said, "While we admit no wrongdoing and continue to believe that our distribution practices did not violate the antitrust laws, this marks final resolution of the multi-year FTC investigation."
News For IDXX From The Last 14 Days
Check below for free stories on IDXX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 22, 2014
07:08 EDTIDXXLife Sciences highlights this week at Canaccord
Canaccord highlighted six diagnostic names that report this week and recommends buying Top Pick IDEXX (IDXX) into the print given strong recurring razor/razorblade sales and consistent organic growth. The analyst expects Hold rated Quest Diagnostics (DGX) to report upside to Street estimates of $1.06/$1.882B, Quidel (QDEL) to have an uneventful report, Exact Sciences (EXAS) to provide an update on numerous catalysts near-term and Abaxis (ABAX) to report earnings below consensus. Lastly, the firm is cautious on Meridian Bioscience (VIVO) following a competitor report last week.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use